ISO-690 (author-date, English)

EMELIYANOVA P, PARKES LM, LEA-CARNALL C und WILLIAMS SR, 2026. Influence of Basis Set Composition on Metabolite Quantification of 1 H-MRS at 3 T: Combining In Silico, In Vivo and In Vitro Evidence. NMR in biomedicine. 1 März 2026. Vol. 39, no. 3, p. e70230-e70230. DOI 10.1002/nbm.70230.

Elsevier - Harvard (with titles)

Emeliyanova P, Parkes LM, Lea-Carnall C, Williams SR, 2026. Influence of Basis Set Composition on Metabolite Quantification of 1 H-MRS at 3 T: Combining In Silico, In Vivo and In Vitro Evidence. NMR in biomedicine 39, e70230-e70230. https://doi.org/10.1002/nbm.70230

American Psychological Association 7th edition

Emeliyanova P, Parkes LM, Lea-Carnall C, & Williams SR. (2026). Influence of Basis Set Composition on Metabolite Quantification of 1 H-MRS at 3 T: Combining In Silico, In Vivo and In Vitro Evidence. NMR in Biomedicine, 39(3), e70230-e70230. https://doi.org/10.1002/nbm.70230

Springer - Basic (author-date)

Emeliyanova P, Parkes LM, Lea-Carnall C, Williams SR (2026) Influence of Basis Set Composition on Metabolite Quantification of 1 H-MRS at 3 T: Combining In Silico, In Vivo and In Vitro Evidence.. NMR in biomedicine 39:e70230-e70230. https://doi.org/10.1002/nbm.70230

Juristische Zitierweise (Stüber) (Deutsch)

Emeliyanova P/ Parkes LM/ Lea-Carnall C/ Williams SR, Influence of Basis Set Composition on Metabolite Quantification of 1 H-MRS at 3 T: Combining In Silico, In Vivo and In Vitro Evidence., NMR in biomedicine 2026, e70230-e70230.

Bitte prüfen Sie die Zitate auf Korrektheit, bevor Sie diese in Ihre Arbeit einfügen.